ProfessionalLive ClassesNo New Dates

Legislative Horizons in Psychedelic Therapy: What Clinicians Need to Know | Fluence

This webinar reviews the current and emerging U.S. policy landscape for psychedelic therapy. It explains how legislation becomes regulation and how clinicians can stay informed about an evolving area without needing to become policy experts.

Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-07).

Provider

English

Details

1 Hour

Course Overview

Legislative Horizons in Psychedelic Therapy: What Clinicians Need to Know is a webinar focused on the policy environment shaping psychedelic therapy in the United States. The session covers how legislation moves into regulation and why early-stage programs often involve uncertainty. The content is geared toward clinicians and therapists who want a clearer understanding of the legal and regulatory context around psychedelic-assisted care. It emphasizes practical awareness rather than deep policy specialization. The course is described as a one-hour webinar. It is presented in a format that helps attendees track policy developments and consider how they may affect clinical practice.

Who is this for?

Clinicians and therapists interested in the policy and regulatory context of psychedelic therapy.

About the Provider

Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.

View Fluence profile

Last verified April 7, 2026

Source: fluencetraining.com (inferred)

Open source URL

Course Details

  • PriceFree
  • FormatLive Classes
  • Lifecycle statusNo New Dates
  • Skills
    Harm ReductionIntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyEthicsInterpreting the transition from legislation to regulationRecognizing uncertainty in early-stage programs
Enroll in Course

You will be redirected to the provider's website